Holen Sie sich die Stockscreener-App
10.74
0.56%
-0.06
Handel nachbörslich:
10.53
-0.21
-1.96%
Schlusskurs vom Vortag:
$10.80
Offen:
$10.5
24-Stunden-Volumen:
24,922
Relative Volume:
0.26
Marktkapitalisierung:
$57.47M
Einnahmen:
$7.97M
Nettoeinkommen (Verlust:
$-75.74M
KGV:
-0.4422
EPS:
-24.2853
Netto-Cashflow:
$-85.33M
1W Leistung:
-2.89%
1M Leistung:
+34.25%
6M Leistung:
-25.10%
1J Leistung:
-8.52%
1-Tages-Spanne:
$10.01
$10.77
1-Wochen-Bereich:
$10.01
$11.19
52-Wochen-Spanne:
$3.76
$46.80
Aligos Therapeutics Inc Stock (ALGS) Company Profile
Firmenname
Aligos Therapeutics Inc
Sektor
Branche
Telefon
(800) 466-6059
Adresse
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO
Vergleichen Sie ALGS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALGS
Aligos Therapeutics Inc
|
10.74 | 73.82M | 7.97M | -75.74M | -85.33M | -24.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-08-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-01-06 | Hochstufung | Jefferies | Hold → Buy |
| 2023-01-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-03-23 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-01-06 | Herabstufung | Jefferies | Buy → Hold |
| 2021-09-09 | Eingeleitet | SVB Leerink | Outperform |
| 2021-05-17 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-11-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-10 | Eingeleitet | JP Morgan | Overweight |
| 2020-11-10 | Eingeleitet | Jefferies | Buy |
| 2020-11-10 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Aligos Therapeutics Inc Aktie (ALGS) Neueste Nachrichten
Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting - The Manila Times
Breakthrough HBV Drug Shows Direct cccDNA Reduction: Aligos Therapeutics Unveils Game-Changing Results - Stock Titan
Aligos Therapeutics Inc. stock trend outlook and recovery path2025 Year in Review & Smart Money Movement Tracker - Newser
Aligos Therapeutics describes new PD-1/PD-L1 interaction inhibitors - BioWorld MedTech
How to monitor Aligos Therapeutics Inc. with trend dashboardsIndex Update & Advanced Swing Trade Entry Plans - Newser
Aligos Therapeutics Inc.’s volatility index tracking explainedMarket Activity Recap & Real-Time Volume Analysis - Newser
What does recent volatility data suggest for Aligos Therapeutics Inc.2025 Stock Rankings & Community Consensus Stock Picks - Newser
Intraday pattern recognizer results for Aligos Therapeutics Inc.2025 Trading Recap & Growth Focused Entry Reports - Newser
Aligos Therapeutics Inc. stock trendline breakdownJuly 2025 Final Week & Weekly Top Performers Watchlists - Newser
Real time breakdown of Aligos Therapeutics Inc. stock performanceBear Alert & Daily Market Momentum Tracking - Newser
Aligos Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference - The Manila Times
Clinical-Stage Liver Disease Developer Aligos Therapeutics to Share Updates at Global Investment Conference - Stock Titan
What chart patterns are forming on Aligos Therapeutics Inc.Quarterly Portfolio Report & AI Enhanced Trading Alerts - khodrobank.com
Can a trend reversal in Aligos Therapeutics Inc. lead to recoveryQuarterly Profit Review & Real-Time Stock Entry Alerts - Newser
Combining price and volume data for Aligos Therapeutics Inc.Market Activity Summary & Real-Time Volume Analysis Alerts - Newser
Will Aligos Therapeutics Inc. bounce back from current supportJuly 2025 Volume & Consistent Profit Trading Strategies - Newser
Risk vs reward if holding onto Aligos Therapeutics Inc.2025 Price Action Summary & Long-Term Growth Plans - Newser
Heatmap analysis for Aligos Therapeutics Inc. and competitorsMarket Growth Report & Smart Allocation Stock Tips - Newser
Candlestick signals on Aligos Therapeutics Inc. stock todayMarket Risk Report & Smart Investment Allocation Tips - Newser
What’s next for Aligos Therapeutics Inc. stock priceGap Down & Low Drawdown Momentum Ideas - Newser
Short interest data insights for Aligos Therapeutics Inc.Market Sentiment Summary & AI Optimized Trading Strategy Guides - Newser
Is Aligos Therapeutics Inc. stock undervalued right nowStock Surge & Fast Exit/Entry Strategy Plans - khodrobank.com
What’s the fair value of Aligos Therapeutics Inc. stockJuly 2025 Rallies & Stock Market Timing Techniques - khodrobank.com
Will Aligos Therapeutics Inc. benefit from geopolitical trendsQuarterly Market Review & Risk Controlled Stock Pick Alerts - khodrobank.com
Aligos Therapeutics Inc. stock momentum explainedWeekly Risk Summary & AI Optimized Trading Strategy Guides - Newser
Aligos Therapeutics Inc. Breakout Confirmed by Volume Metrics getLinesFromResByArray error: size == 0 - kangso.co.kr
Will Aligos Therapeutics Inc. outperform tech stocksWeekly Gains Summary & Intraday High Probability Setup Alerts - خودرو بانک
Will Aligos Therapeutics Inc. continue its uptrendInsider Buying & Weekly Stock Performance Updates - Newser
Backtesting results for Aligos Therapeutics Inc. trading strategies2025 Buyback Activity & Stepwise Entry and Exit Trade Signals - Newser
Evaluating Aligos Therapeutics Inc. with trendline analysis2025 Breakouts & Breakdowns & Fast Gain Swing Trade Alerts - Newser
Reversal indicators forming on Aligos Therapeutics Inc. stockCPI Data & High Return Stock Watch Alerts - Newser
Why Aligos Therapeutics Inc. stock attracts strong analyst attentionMarket Activity Recap & Weekly Sector Rotation Insights - Newser
Best data tools to analyze Aligos Therapeutics Inc. stockMarket Growth Summary & Real-Time Volume Trigger Notifications - Newser
What is the target price for Aligos Therapeutics Inc. stockMarket Activity Report & AI Enhanced Trading Alerts - sundaytimes.kr
Aligos Therapeutics Inc. Builds Base for Possible Rebound getLinesFromResByArray error: size == 0 - kangso.co.kr
Will Aligos Therapeutics Inc. stock go up soonStop Loss & Low Drawdown Investment Strategies - Newser
Can you recover from losses in Aligos Therapeutics Inc.July 2025 Intraday Action & Fast Gain Stock Tips - Newser
Finanzdaten der Aligos Therapeutics Inc-Aktie (ALGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):